122 related articles for article (PubMed ID: 2256916)
1. Inhibition of EGF-induced phospholipase C activation in A431 cells by erbstatin, a tyrosine kinase inhibitor.
Imoto M; Shimura N; Ui H; Umezawa K
Biochem Biophys Res Commun; 1990 Nov; 173(1):208-11. PubMed ID: 2256916
[TBL] [Abstract][Full Text] [Related]
2. Stimulation or inhibition of A431 cell growth by EGF is directly correlated with receptor tyrosine kinase concentration but not with PLC gamma activity.
Chen JK; Lin SS
Life Sci; 1993; 53(8):635-42. PubMed ID: 8350679
[TBL] [Abstract][Full Text] [Related]
3. Involvement of tyrosine kinase in growth factor-induced phospholipase C activation in NIH3T3 cells.
Imoto M; Sujikai I; Ui H; Umezawa K
Biochim Biophys Acta; 1993 Feb; 1166(2-3):188-92. PubMed ID: 8443236
[TBL] [Abstract][Full Text] [Related]
4. Stimulation by epidermal growth factor of inositol phosphate production in plasma membranes from A431 cells.
Payrastre B; Plantavid M; Chap H
Biochim Biophys Acta; 1991 Jan; 1056(1):19-26. PubMed ID: 1984783
[TBL] [Abstract][Full Text] [Related]
5. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
Decker SJ; Ellis C; Pawson T; Velu T
J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
[TBL] [Abstract][Full Text] [Related]
6. In situ inhibition of tyrosine protein kinase by erbstatin.
Imoto M; Umezawa K; Sawa T; Takeuchi T; Umezawa H
Biochem Int; 1987 Nov; 15(5):989-95. PubMed ID: 3501720
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CDP-DG: inositol transferase by inostamycin.
Imoto M; Taniguchi Y; Umezawa K
J Biochem; 1992 Aug; 112(2):299-302. PubMed ID: 1328172
[TBL] [Abstract][Full Text] [Related]
8. Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells.
Takekura N; Yasui W; Kyo E; Yoshida K; Kameda T; Kitadai Y; Abe K; Umezawa K; Tahara E
Int J Cancer; 1991 Apr; 47(6):938-42. PubMed ID: 1849125
[TBL] [Abstract][Full Text] [Related]
9. Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells.
Wahl MI; Daniel TO; Carpenter G
Science; 1988 Aug; 241(4868):968-70. PubMed ID: 2457254
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
Liang M; Garrison JC
Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of EGF-induced cytoskeletal change in A431 cells by inhibitors of phosphatidylinositol turnover.
Johtoh N; Umezawa K
Drugs Exp Clin Res; 1992; 18(1):1-7. PubMed ID: 1600863
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium.
Wahl MI; Nishibe S; Suh PG; Rhee SG; Carpenter G
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1568-72. PubMed ID: 2466293
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the epidermal growth factor receptor and non-tyrosine kinase hormone receptors stimulate phosphoinositide hydrolysis by independent pathways.
Hepler JR; Jeffs RA; Huckle WR; Outlaw HE; Rhee SG; Earp HS; Harden TK
Biochem J; 1990 Sep; 270(2):337-44. PubMed ID: 1698055
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of phospholipase C-gamma 1 membrane association by epidermal growth factor.
Todderud G; Wahl MI; Rhee SG; Carpenter G
Science; 1990 Jul; 249(4966):296-8. PubMed ID: 2374928
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors.
Umezawa K; Hori T; Tajima H; Imoto M; Isshiki K; Takeuchi T
FEBS Lett; 1990 Jan; 260(2):198-200. PubMed ID: 2298299
[TBL] [Abstract][Full Text] [Related]
16. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin.
Bishop WR; Petrin J; Wang L; Ramesh U; Doll RJ
Biochem Pharmacol; 1990 Nov; 40(9):2129-35. PubMed ID: 2242040
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells.
Imoto M; Taniguchi Y; Fujiwara H; Umezawa K
Exp Cell Res; 1994 May; 212(1):151-4. PubMed ID: 7909754
[TBL] [Abstract][Full Text] [Related]
19. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.
Thurston AW; Rhee SG; Shukla SD
J Pharmacol Exp Ther; 1993 Aug; 266(2):1106-12. PubMed ID: 7689100
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes.
Reynolds NJ; Talwar HS; Baldassare JJ; Henderson PA; Elder JT; Voorhees JJ; Fisher GJ
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):535-44. PubMed ID: 7690546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
